title: Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents.
authors.forename: Y
authors.initials: Y
authors.lastname: Wada
authors.forename: D
authors.initials: D
authors.lastname: Kobayashi
authors.forename: S
authors.initials: S
authors.lastname: Murakami
authors.forename: M
authors.initials: M
authors.lastname: Oda
authors.forename: H
authors.initials: H
authors.lastname: Hanawa
authors.forename: T
authors.initials: T
authors.lastname: Kuroda
authors.forename: M
authors.initials: M
authors.lastname: Nakano
authors.forename: I
authors.initials: I
authors.lastname: Narita
mesh_terms: D000368:Aged; D000686:Amyloidosis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D000974:Antibodies, Antinuclear / Q000097:blood; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications*; D001562:Benzimidazoles / Q000627:therapeutic use; D001713:Biphenyl Compounds; D002227:Carbazoles / Q000627:therapeutic use; D000077261:Carvedilol; D004359:Drug Therapy, Combination; D004417:Dyspnea / Q000175:diagnosis / Q000188:drug therapy; D000068800:Etanercept; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006225:Hand / Q000000981:diagnostic imaging; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D017563:Lung Diseases, Interstitial / Q000175:diagnosis / Q000000981:diagnostic imaging; D020097:Natriuretic Peptide, Brain / Q000097:blood; D011412:Propanolamines / Q000627:therapeutic use; D011859:Radiography; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D012217:Rheumatoid Factor / Q000097:blood; D012263:Ribonucleosides / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000150:complications*; D013148:Spironolactone / Q000627:therapeutic use; D012460:Sulfasalazine / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000974:Antibodies, Antinuclear; D018501:Antirheumatic Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D002227:Carbazoles; D005938:Glucocorticoids; D007074:Immunoglobulin G; D011412:Propanolamines; D018124:Receptors, Tumor Necrosis Factor; D012263:Ribonucleosides; D013777:Tetrazoles; D000077261:Carvedilol; D020097:Natriuretic Peptide, Brain; D013148:Spironolactone; D012460:Sulfasalazine; C010052:mizoribine; D005665:Furosemide; D012217:Rheumatoid Factor; D000068800:Etanercept; C081643:candesartan